Heart valves with increased effective orifice area

Information

  • Patent Grant
  • 10441415
  • Patent Number
    10,441,415
  • Date Filed
    Wednesday, September 17, 2014
    9 years ago
  • Date Issued
    Tuesday, October 15, 2019
    4 years ago
Abstract
A prosthetic heart valve for implant in a human. The valve includes a wireform with undulating inflow cusps and outflow commissure posts to which flexible leaflets attach and coapt in a flow area. Each leaflet may drape over the top of the wireform in the cusp area, but have tabs that each extend underneath the wireform at the commissure posts to be secured along with a tab of an adjacent leaflet. The prosthetic heart valve may also be a dual-wire wireform, with the leaflets sandwiched therebetween. One wireform may be larger than the other, with the leaflets extending over the smaller wireform. The smaller wireform may have commissures that bend radially outward from the larger wireform to provide structure to which the leaflet tabs attach.
Description
FIELD OF THE INVENTION

The present invention relates to a prosthetic heart valve having increased flow area for enhanced flow and, more particularly, to a flexible leaflet valve with modified stent and leaflet structure that increases the effective orifice area for a given valve size.


BACKGROUND OF THE INVENTION

Heart valve disease continues to be a significant cause of morbidity and mortality, resulting from a number of ailments including rheumatic fever and birth defects. Currently, the primary treatment of aortic valve disease is valve replacement. Worldwide, approximately 300,000 heart valve replacement surgeries are performed annually, many involving mechanical heart valves composed of rigid, synthetic materials while the rest receive bioprosthetic heart valves which utilize biologically derived tissues for flexible fluid occluding leaflets. In general, bioprosthetic valve replacements have good hemodynamic performance and do not require the anticoagulation therapy necessary for mechanical heart valves.


Flexible leaflets used in heart valves are typically made from bioprosthetic homograft or xenograft materials. For example, the most successful bioprosthetic materials are whole porcine valves and separate leaflets made from bovine pericardium stitched together to form a tri-leaflet valve. In addition, flexible leaflets formed of polymeric, fiber-reinforced, and other synthetic materials have been proposed. The most common bioprosthetic valve construction includes three leaflets mounted around a peripheral support structure with free edges that project toward an outflow direction and meet or coapt in the middle of the flowstream.


Aortic stenosis is abnormal narrowing of the aortic valve characterized by a significantly higher than normal pressure gradient across the aortic valve. It follows that an important characteristic of a replacement aortic valve is minimal aortic pressure gradient, typically attained by increasing the effective orifice area through the valve. Solutions include placement of the prosthesis (sub-annular, intra-annular and supra-annular) in order to implant a prosthesis with the largest possible effective orifice area. Supra-annular placement (where the sewing cushion lies above the aortic annulus) is often preferred because usually a valve with a larger internal orifice diameter can be implanted. However, in patients with small aortic roots, either due to anatomy, physical stature, or severe calcification, only the smallest-sized valves (e.g., 19 mm) may be used. Sometimes an even smaller valve would be desirable, but valves smaller than 19 mm are not commercially available. Moreover, even with a supra-annular implant, the valve often does not maximize the flow orifice area.


In view of actual and perceived drawbacks associated with current bioprosthetic heart valves, a valve with an increased effective orifice area for a given valve size is desirable.


SUMMARY OF THE INVENTION

The present application provides a low pressure gradient prosthetic heart valve for implant in a human. The valve includes a wireform with undulating inflow cusps and outflow commissure posts to which flexible leaflets attach and coapt in a flow area.


One aspect of the present application is a prosthetic heart valve comprising a first cloth-covered undulating wireform having alternating cusps and commissures around a periphery. A second cloth-covered undulating wireform has alternating cusps and commissures around a periphery, and the cusps and commissures of the two wireforms are aligned with one another. A plurality of flexible leaflets have outer edges sandwiched between the cusps of the first and second cloth-covered undulating wireforms. In one embodiment, the flexible leaflets have commissure edges sandwiched between the commissures of the first and second cloth-covered undulating wireforms. A cloth tab on one of the wireforms may encompass a small piece of silicone ribbon at least at the cusps thereof to provide a sewing ring.


The first and second wireforms may have similar sizes and shapes, with the cusps curving in an inflow direction and the commissures defining upstanding commissure posts with inverted U-shapes projecting in an outflow direction. The first wireform may be slightly smaller in radius and shorter in axial dimension than the second wireform which is positioned outward from the first wireform except at the aligned commissures where the first wireform bends outward so that its commissures are radially outside the second wireform and provide sewing anchors for commissure tabs of the flexible leaflets. The flexible leaflets preferably have tabs that are sandwiched between the first and second wireforms at the aligned commissures. In one version, the tabs of the flexible leaflets wrap around the first wireform and are attached thereto at the aligned commissures.


In another embodiment, the cusps of both wireforms curve in an inflow direction and the commissures of the second wireform define upstanding commissure posts with inverted U-shapes projecting in an outflow direction, wherein the first wireform has truncated commissures of about one half the height of the commissures of the second wireform. The flexible leaflets may have commissure tabs that extend outward through the inverted U-shaped commissures of the second cloth-covered wireform and are secured to cloth tabs extending from the cloth covering the second wireform.


In another embodiment, a prosthetic heart valve comprises a cloth-covered undulating wireform with alternating cusps and commissures, the commissures extending generally axially in an outflow direction and defining inverted U-shaped commissure posts. A plurality of flexible leaflets have outer cusp edges that extend over the top of the cusps of the wireform, and each of the leaflets has a free-edge that, when implanted, moves back and forth in and out of the flow orifice and coapts with the free edges of the other leaflets. Each leaflet also has tabs at either end of the free edge that project radially outward under the inverted U-shaped commissure posts and are secured thereto along with a tab from an adjacent leaflet.


The outer cusp edge of each leaflet desirably interrupted by two inwardly-directed slits that each receive a portion of the wireform near the U-shaped commissures on either side of the leaflet to permit the leaflet tabs to pass under the U-shaped commissures. The inwardly-directed slits may terminate in a rounded hole to closely conform around the wireform. A reinforced strip of material may be attached around the rounded holes, or more generally around the termination of the slits.


In a further embodiment, a prosthetic heart valve comprises a cloth-covered undulating wireform with alternating cusps and commissures, the commissures extending generally axially in an outflow direction and defining inverted U-shaped commissure posts, with the commissures bent outward and then generally axially again. A plurality of flexible leaflets have outer cusp edges that extend over the top of the cusps of the wireform, and each of the leaflets has a free-edge that, when implanted, moves back and forth in and out of the flow orifice and coapts with the free edges of the other leaflets. Each leaflet having tabs at either end of the free edge that project radially outward around the outside of the inverted U-shaped commissure posts. A commissural clip extends over the top of each wireform and leaflet tab at the commissures and is sewn to the cloth-covered wireform and leaflet tabs to secure the leaflet tabs around the wireform. The commissural clips may have a closed oval shape. The cloth tab on the wireform preferably encompasses a small piece of silicone ribbon at least at the cusps thereof to provide a sewing ring.


A further understanding of the nature and advantages of the present invention are set forth in the following description and claims, particularly when considered in conjunction with the accompanying drawings in which like parts bear like reference numerals.





BRIEF DESCRIPTION OF THE DRAWINGS

Features and advantages of the present invention will become appreciated as the same become better understood with reference to the specification, claims, and appended drawings wherein:



FIG. 1 is a plan view looking from the outflow end of a flexible leaflet bioprosthetic heart valve of the prior art;



FIG. 2 is a perspective view of certain inner components of the heart valve of FIG. 1;



FIG. 3 is a partially cutaway view of the assembled heart valve of FIG. 1;



FIG. 4 is a perspective view of an inner stent assembly for the prior art heart valve of FIG. 1;



FIG. 5 is an enlarged perspective view of a commissure region of the heart valve of FIG. 1 with cloth coverings removed for clarity;



FIG. 6 is a plan view looking from the outflow end of an alternative flexible leaflet bioprosthetic heart valve of the prior art;



FIG. 7 is a partially disassembled perspective view of the heart valve of FIG. 6 showing certain internal components;



FIG. 8 is a perspective view of the assembled heart valve of FIG. 6;



FIGS. 9A-9B are perspective views of a portion of a bioprosthetic heart valve of the present application shown closed and open, respectively, and FIG. 9C is an enlargement of one corner of a leaflet;



FIGS. 10A-10B are radial sectional views through a cusp region of the heart valve of FIGS. 9A and 9B showing an exemplary attachment between flexible leaflets and wireform;



FIG. 10C is a radial sectional view similar to FIG. 10B and illustrating the difference in flow orifice area between attaching the flexible leaflets underneath and over the wireform;



FIGS. 11A-11B are perspective views of a portion of an alternative dual-wireform bioprosthetic heart valve of the present application shown closed and open, respectively;



FIGS. 12A-12B are radial sectional views through a cusp region of the heart valve of FIGS. 11A and 11B showing an exemplary attachment between flexible leaflets and the dual wireforms;



FIG. 12C is a radial sectional view similar to FIG. 12B and illustrating the difference in flow orifice area between attaching the flexible leaflets underneath and over an inner wireform;



FIG. 13 is a perspective view of an assembled heart valve as in FIGS. 11A and 11B with dual wireforms which cross over each other at the commissure regions;



FIG. 14 is a perspective view of a still further prosthetic heart valve of the present application having a single wireform and clips at the commissure regions;



FIG. 15 is a perspective view of a dual-wireform prosthetic heart valve;



FIG. 16 illustrates one step in a procedure for assembling the dual-wireform prosthetic heart valve of FIG. 15;



FIGS. 17A-17C are radial sectional views through cusps of a dual-wireform prosthetic heart valve of the present application;



FIGS. 18A and 18B illustrate two different implantation configurations for the dual-wireform prosthetic heart valves disclosed herein;



FIGS. 19A and 19B are exploded and assembled views of two wireforms in an alternative dual-wireform prosthetic heart valve having a truncated lower wireform; and



FIGS. 20A and 20B are detailed views of a commissure post region of an assembled heart valve of FIGS. 19A and 19B showing one way to attach flexible leaflets to an upper wireform.





DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

The present application describes certain principles that may be used in conjunction or separately for fabricating flexible leaflet prosthetic heart valves to reduce the pressure gradient of blood through the valve orifice. As general statements of benefits obtained from such a valve: the valve should open properly upon forward flow with minimal gradient; the valve should close properly and completely upon reverse flow with little regurgitation; the support structure (e.g., wireform) of the valve should be able to withstand the fatigue stress during a large number of the valve open/close cycles and maintain structural integrity; and the flexible leaflets should withstand the structural stress and maintain the structural function of opening and closing without calcification or structural deterioration.


The desire for these attributes is not necessarily new in the field of prosthetic heart valve design, but valves constructed based on the principles described herein improve on each, in particular by increasing the effective flow orifice area through the valve for a given size. It should be understood that the characteristics of heart valves expressed herein may be implemented in a variety of different flexible leaflet valves. For example, though three- or tri-leaflet valves are the most common and most studied, only two or a greater number of leaflets may also be used. Also, the support frame, or structural skeleton, for the flexible leaflets may take a variety of forms in addition to those illustrated and described herein. The valve support frame may be relatively dimensionally stable, or configured to be collapsible for minimally-invasive delivery. Finally, materials and fabrication techniques may vary while still conforming any valve to the described desirable principles. In summary, the present application encompasses many valves that include one or more of these variable aspects, only limited by the appended claims.


As used herein, a “neutral position” or a “neutral configuration” means a configuration of a valve and/or a frame when the respective valve and/or frame is at-rest (e.g., still) and free from externally applied loads (e.g., pressure gradients through the valve, forces applied by retaining and/or delivery devices to retain the valve in a collapsed configuration), and is not biased toward any other shape.


Further, the term “wireform” refers to an elongated rod-like structure formed into a continuous shape defining a circumference around a flow orifice for supporting flexible leaflets in the various prosthetic valves herein. Typically a wireform has an undulating shape with alternating inflow cusps and outflow commissures; usually three each. The wireforms described herein may be machined from tubes or wires, or may be molded if made of a polymer. The continuous structure may be homogenous with no joints, or a crimp may be used to join two ends of a preformed wire. The cross-section may be round, oval, square or other suitable configuration.


A prosthetic heart valve 20 of the prior art shown in FIGS. 1-5 includes an inlet end 22 and an outlet end 24 (FIG. 3) separated along a generally vertical flow axis 26 through approximately the middle of the valve. (It should be noted that blood flow through a heart valve is not precisely like flow through a tubular pipe, and thus the term “flow axis” should be understood to be an approximation and refers generally to an axis through the center of the valve orifice.) A cloth-covered support frame includes an annular stent assembly 28 and an annular wireform 30. The support frame defines a periphery and flow orifice of the valve. Both the stent assembly 28 and wireform 30 include commissure posts that project generally axially in the outflow direction and combine to form commissures 32 of the valve when covered with fabric. Both stent assembly 28 and wireform 30 also include arcuate cusps that curve in the inflow direction in between each two commissures that combine to form valve cusps 34. In the illustrated embodiment, the stent assembly 28 includes two annular bands, an outer metallic band and an inner polyester band that extends up the commissures. Three flexible leaflets 36 couple to the support frame and extend inward therefrom. The leaflets 36 attach along an undulating line that follows the commissures 32 and cusps 34. A suture-permeable sewing ring 38 surrounds the inflow end of the valve 20 and, as shown, features a non-planar peripheral shape which undulates upward a short distance in the vicinity of the three commissures 32. A planar sewing ring 38 may also be used.


The leaflets 36 may be provided by a whole porcine valve, but are preferably formed individually from bioprosthetic material such as bovine pericardium. It should be noted that a number of advantages of the present application are independent of the type of flexible leaflet, though the maximum benefit will be obtained by using sheets of bovine pericardium trimmed to particular sizes and shapes, as will be explained. Although not presently used in commercial valves, synthetic material may also be used for the leaflets, and the term, “flexible leaflets” is meant to include such other materials.


The prosthetic heart valves illustrated in FIGS. 1-5 represents the construction of a Carpentier-Edwards mitral pericardial valve, one of the leading commercially available bioprosthetic valves, available from Edwards Lifesciences of Irvine, Calif. The assembly process for the Carpentier-Edwards valve includes sewing the pericardial leaflets 36 to a cloth-covered wireform 30, and then this subassembly is mounted to a cloth-covered stent assembly 28 having a silicone sewing ring 38 connected thereto with sutures. The cloth covering of each component and their subsequent assembly is elaborate and labor-intensive.


However, this particular valve construction has a proven track record, partly because of the highly durable configuration where the valve leaflets 36 connect to the valve commissures 32. With reference to the enlarged view in FIG. 5, the leaflets 36 extend underneath the wireform 30 and outward through adjacent wires at the commissures 32, and are sandwiched between the wireform and a cloth tab (not shown) provide on the stent assembly 28. Commissure tabs 40 of adjacent leaflets 36 project through the commissure regions of the wireform 30 and wrap around the commissure posts of the stent assembly 28. By wrapping the leaflet tabs 40 in this manner, and securing them on the exterior of the stent assembly 28, the relatively high inward forces imparted to the free edges of the leaflets 36 from when the leaflets close are distributed to the stent assembly 28 and wireform 30, not just to sutures connecting the leaflets to the surrounding structure.



FIG. 1A shows the bioprosthetic heart valve 20 with the leaflets 36 closed. In use, the leaflets 36 open or separate from blood flow from the inflow end 22 to the outflow end 24, or in the outflow direction. Typical valves of the prior art have relatively floppy leaflets 36 that generally effectively coapt or meet in the flow orifice during the back flow portion of the flow cycle, as in FIGS. 1-3. The commissures 32 usually tilt somewhat inwardly relative to the central flow axis 26 from their inflow to their outflow ends so as to define a surface of revolution that surrounds a converging conical volume. This arrangement provides a flow constriction wherein the size of the orifice provided by the commissure posts 32 and leaflets 36 in the valve open state is smaller than the generally circular orifice defined at the inflow end 22. The combination of the generally conical flow column and typical valve assembly introduces flow restrictions that increase the fluid pressure gradient through the valve as opposed to a smooth cylinder, or idealized pipe flow.



FIGS. 6-8 illustrate construction of another commercially-available bioprosthetic heart valve 50, the Trifecta™ aortic valve available from St. Jude Medical of St. Paul, Minn. The valve 50 includes an inner polymer stent 52 having three generally axially-aligned commissure posts 54, and a sewing ring 56 surrounding the inflow end of the stent. A single sheet of bioprosthetic tissue 58 wraps around the outside of the stent 52 and is sewn thereto with sutures 60 along its commissure posts 54, and also along a peripheral line adjacent the sewing ring 56. The bioprosthetic tissue 58 is slightly taller than the stent commissure posts 54 to help provide enough free leaflet material ostensibly for good coaptation in the flow orifice. However, the extra leaflet material above the commissure posts 54 sometimes leads to leaflet prolapse, or poor coaptation and durability. Other so-called wrap-around designs of heart valves in the prior art include the Mitroflow valve from the Sorin Group of Milan, Italy, and the Ionescu-Shiley valve from Shiley Labs of Irvine, Calif.


The present application provides prosthetic heart valves that are constructed to have proven durability and to maximize effective orifice area. More particularly, the heart valves described herein have flexible leaflets that are connected to a wireform/stent structure much like the Edwards Lifesciences Carpentier-Edwards valves described above with respect to FIGS. 1-5. At the same time, the flexible leaflets are attached over the top of at least one part of the wireform to increase the orifice area. The wireform may be provided in one or two parts.


With reference now to FIG. 9A, a prosthetic heart valve 70 of the present application is represented by a single leaflet 72 (out of three) and its positional relationship to one third of a wireform 74. The wireform 74 extends in an undulating pattern (alternating cusps and commissures) around the entire heart valve, as with wireforms of the prior art. The reader will understand that additional constructional details such as the stent assembly or sewing ring are not shown for clarity. The leaflet 72 includes a free edge 76 that coapts within the orifice defined by the valve with the other leaflets (not shown). The free edge 76 of the leaflet terminates at either end in tabs 78. As with the Carpentier-Edwards heart valve described above, the leaflet tabs 78 extend outward underneath the inverted U-shaped commissures of the wireform 74 and preferably wrap around and are sewn to commissure posts of a stent structure (not shown). The leaflet 72 additionally has an arcuate cusp edge 80 that is secured around a cusp of the wireform 74, but instead of extending underneath the wireform and being sandwiched against the underlying stent structure, the leaflet 72 extends over the top of the wireform cusp 74, such as shown in FIG. 10A. Although not shown, the wireform 74 will again be cloth-covered, and the outer arcuate cusp edge 80 will be secured to an outer tab on the cloth covering with sutures, for example. In one embodiment, the outer cusp edge 80 wraps over and underneath the wireform 74 during assembly.


To enable this over-under attachment of the leaflet 72, a gap or slot 86 is provided between each leaflet tab 78 and the adjacent portion of the outer cusp edge 80. The slot 86 has a width that is approximately equal to the diameter of the wireform 74, and extends generally radially inward from the curved outer cusp edge 80 of the leaflet. To help prevent blood leakage in the area near the slot 86, additional fabric can be sewn around that area to secure the leaflet 72 as well as close any holes that might leak. An alternative to the slot 86 is a small hole in the leaflet 72 having a diameter approximately equal to the diameter of the wireform 74. In this embodiment, the “gap” between the tabs 78 and the cusp edge 80 can be a slit cut in the leaflet (i.e., the gap width is zero) from its cusp edge to the small hole. Alternatively, the slot 86 may be located within the tab 78 which helps facilitate attachment and conceal any opening that might leak.


In one embodiment, the slot 86 is reinforced to help prevent tearing. For example, FIG. 9C shows an enlargement of one corner of the leaflet where the area around the slot has a reinforced strip 87. The strip 87 may be an added layer of bioprosthetic tissue, or a section of fabric such as Dacron. Alternatively, the slot 86 may terminate in a rounded hole to closely conform around the wireform 74 and reduce points of high stress, as well as having the reinforced strip 87. Another possibility is to leave the portion of the leaflet 72 around the slot 86 much thicker than the rest of the leaflet, such as by cutting the leaflet from particular areas of the pericardial sac, or by thinning the rest of the leaflet.


It should also be noted that the length of the leaflet free edge 76 between the tabs 78 is designed to encourage full opening of the leaflet. If R is the wireform radius at the location of its commissures, then the length of the leaflet free edge 76 is equal to at least about 2πR/3.



FIG. 9A illustrates the leaflet 72 in its closed position, with the free edge 76 bowed inward so that its midpoint lies essentially along a central flow axis through the valve and coapts with the other two leaflets. FIG. 10A shows the leaflet 72 extending inward over the wireform 74. Conversely, FIG. 9B shows the leaflet 72 in its open configuration with blood flow 82 indicated by upward arrows through the flow orifice. As can be seen in FIG. 10B, positioning the outer edge of the leaflet 72 over the top of the wireform 74 maximizes the effective orifice area by eliminating any impediment to flow caused by the leaflet 72 projecting inward from the wireform 74. FIG. 10C illustrates a leaflet 84 of the prior art attached underneath the wireform 74, and also shows the new arrangement with the leaflet 72 attached over the wireform. The region in between the two leaflets 72, 84 indicates the area in which flow may be restricted by the “under-the-wireform” leaflet.


In addition to a single-wire wireform such as shown at 74 above, the present application also contemplates a “sandwiched” configuration of a dual-wire wireform, such as shown in FIGS. 11-12. More particularly, a prosthetic heart valve 90 is again represented by a single leaflet 92 shown in its orientation relative to a wireform assembly of an outer wireform 94 and an inner wireform 96. Again, both of the wireforms 94, 96 extend around the periphery of the heart valve in an undulating pattern with cusps and commissures.


The overall profile of the inner wireform 96 is smaller in radius and shorter in axial dimension than the outer wireform 94. However, at the commissure regions, the inner wireform 96 bends outward so that it is radially outside the outer wireform 94 to serve as the sewing anchor for the leaflet tabs 98. That is, the commissures of the inner wireform 96 take the place of the commissure posts of a stent structure, as in the prior art. Adjacent leaflet tabs 98 wrap around the inner wireform 96 and are sewn together. The OD of the inner wireform 96 at the cusp region should be equal to the size of the valve. That is, each valve has an identified size, typically in odd 2 mm increments from 19-29 mm. The inner wireform 96 thus has a diameter at its cusps that is about 19 mm for a size 19 valve, and so on. The inner wireform 96 thus helps to maintain a leaflet opening area as large as the circular opening area of the inner wireform.


The outer wireform 94 follows a similar contour profile as existing wireforms of the prior art, though it has a larger diameter. The leaflet 92 is sandwiched between the two wireforms 94, 96 in the belly area. The leaflets 92 wrap over the inner wireform 96 and then under the outer wireform 94 which keeps the leaflet belly in place. The gap between the inner and outer wireforms 94, 96 in the belly region (center of the cusps) is therefore approximately equal to the thickness of the leaflet 92. In the commissure region, the leaflet tabs 98 pass under the inverted U-shaped commissures of the outer wireform 94, which thus keeps the leaflet tabs together so that the three leaflets maintain the coaptation when closed. The leaflet belly edges can be inserted underneath the outer wireform and then typically sewn together with a sewing ring (not shown). Although a sewing ring is used in conventional heart valves, some newer configurations eliminate it for various reasons. For example, some heart valves attach to the annulus through self-contained structure such as clamps, stents, or barbs, or are otherwise attached without (primarily) using sutures, which is the main purpose of a sewing ring. Also, a soft ring may be provided around the valve to seal against the surrounding annulus and prevent leakage around the valve, but it may not be a conventional sewing ring in that it is not used as the primary anchoring structure with sutures.


The two wireform assembly serves several purposes. The cusp region of the inner wireform 96 keeps the same contour profile and same circular opening diameter as the existing wireform from valves of the prior art. The inner wireform 96 thus helps to maintain a maximum opening profile since the leaflet rests on top of the inner wireform in the belly region. At the same time, the outer wireform 94 keeps the leaflet belly in place and maintains the leaflet tabs 98 together to enhance coaptation. Further, the inner wireform 96 bends outward at the commissures to provide the attachment structure for the leaflet tabs 98, thus eliminating one purpose for the stent structure in prior art valves. Indeed, the entire valve may include the two wireforms 94, 96 covered with cloth and sewn to the leaflets 92, plus a suture-permeable sewing ring 100 (See FIG. 12A) secured around the periphery of the wireform assembly. Again, the sewing ring is shown here as an example only, and may represent a sealing ring or may be eliminated altogether.



FIG. 12A illustrates an exemplary construction where the outer edge of the leaflet 92 is wrapped around the outer wireform 94 and the sewing ring 100 is secured therearound. Each of the wireforms 94, 96 will be covered with fabric, although that has been omitted for clarity. The fabric around the wireforms 94, 96 may be sewn to the sewing ring 100, which typically includes an inner silicone core 102 surrounded by fabric 104. FIG. 12A shows the valve and its closed position with the leaflet 92 caused by fluid backflow to move to the middle of the flow orifice and coapt against the other leaflets.


On the other hand, FIGS. 11B and 12B show the leaflet in an open configuration, with blood flow 106 indicated. Because the leaflet 92 extends over the top of the inner wireform 96, it does not present an impediment to blood flow and thus maximizes the effective orifice area. FIG. 12C again illustrates the position of a leaflet 108 that is attached underneath the inner wireform 96 in the open configuration of the valve. The region 110 in-between this leaflet 108 and a leaflet 92 that extend over the wireform 96 is the difference in orifice flow area which is gained by use of the present valve constructions.



FIG. 13 is a perspective view of an assembled heart valve as in FIGS. 11A and 11B with the dual wireforms 94, 96 which cross over each other at the commissure regions. The outer wireform 94 is always observable, and the inner wireform 96 is covered by the leaflets except at commissure tips which bend to the outside of the outer wirform. The tabs of the leaflets 92 are sandwiched between the outer wireform 94 and inner wireform 96 at the commissural posts. In a preferred embodiment, the tabs of the leaflets 92 wrap around the inner wireform 96, which is not shown because the entire assembly is covered with fabric.


Another alternative prosthetic heart valve 120 is seen in FIG. 14. As with the first environment, there is a single-wire wireform 122 over which the cusp edges of each leaflet 124 attaches. Leaflet tabs 126 wrap around stent commissure posts 128 which are bent outward and then generally axially again to make room for a commissural clip 130. The clips 130 help maintain good leaflet coaptation while reducing stresses in the leaflet for better durability. Once again, because each leaflet 124 extends over the top of the wireform 122, the effective orifice area is maximized. Although not shown, cloth coverings around the wireform 122 and the clips 130 are sewn together to secure the assembly. The clips 130 are shown as closed ovals, though other configurations are possible.



FIG. 15 is a subassembly of a dual-wireform prosthetic heart valve 140 with the leaflets 142 secured therein. An outer cloth-covered wireform 144 attaches under an inner cloth-covered wireform 146. Although not shown, a sewing ring may attach around the cusp portions of the wireforms 144, 146, with the gaps at the commissure portions of the wireforms filled-in with fabric or other such material to prevent leakage.


The dual-wireform valve 140 of FIG. 15 may be assembled as seen in FIG. 16. More particularly, the outer or larger cloth-covered wireform 144 attaches underneath or around the inner cloth-covered wireform 146. Preferably, the flexible leaflets 142 are pre-attached to the inner wireform 146 as shown. The outer wireform 144 may align directly below the inner wireform 146, or may be slightly radially larger.


As seen in FIGS. 17A-17C, the wireforms 144, 146 may be round or square in cross-section, or have another polygonal shape. Wireforms with square or rectangular cross-sections may lock together or stay axially aligned better than wireforms with round cross-sections. It should be noted that the wire diameters of both the inner and outer wireforms 144, 146 can be the same or different so as to change the spring rate, commissure deflection rate, and valve function.


In a preferred embodiment, the wireforms for any of the valves disclosed herein are a cobalt-chromium-nickel alloy such as Elgiloy. However, the wireforms can be formed of any semi-rigid (meaning not floppy) metallic or polymeric materials that possess sufficient elasticity to maintain their shape for delivery and implant yet are capable of flexing to a small degree post-implant from natural systolic-diastolic forces. Elgiloy, stainless steel, titanium, and Nitinol are all possible metallic materials, and various polyester or nylon synthetic materials are options.


As seen in FIGS. 17A-17C, a cloth tab 150 attached to the outer wireform 144 extends beyond a cloth tab 152 attached to the inner wireform 146. A small piece of silicone tubing or ribbon 154 may be added to the larger cloth tab 150 at least at the cusps of the wireform 144 to provide a sewing ring or sorts and larger target for needle penetration. The leaflets 142 are sandwiched between the two wireforms 144, 146, and are sewn thereto through the adjacent cloth tabs 150, 152. It should be noted that the cross-sectional shapes of the wireforms 144, 146 are shown in a variety of ways to emphasize possible combinations; both rounded, one square and one rounded, etc.


In an exemplary implementation procedure, the valve 140 would directly attach to the wall of the aorta using the larger cloth tab 150 of the outer wireform 144. The tab 150 can be bent downward as in FIG. 18A, or upward as in FIG. 18B. The cloth tab 150 extends up and down the wireforms 144, 146, and thus follows the natural scalloped shape of the aortic wall. Although not shown, the attachment of the leaflets 142 at the commissures may be configured the same as any of the other dual-wireform valves disclosed herein, such as by bending the inner wireform 146 radially outward and wrapping leaflet tabs around it.


The highly flexible valve provided by the dual wireform assembly of FIGS. 15-18 greatly improves hemodynamics over aortic valves currently on the market having relatively rigid annular frames. The attachment up and down the commissures at the aorta maximizes the size of valve which can be implanted. It is also anticipated that this valve will have similar durability properties compared to those currently produced since the leaflets are supported from above and below by wireforms. Moreover, the valve 140 also realizes significant cost savings over currently manufactured valves. The relatively simple assembly of the dual wireforms as seen in FIG. 16 replaces the labor-intensive stitching typically required with numerous cloth-covered components.


Moreover, the dual-wireform valve 140 of FIG. 15 eliminates any rigid annular components of the heart valve, which is a fairly standard construction in commercial valves. Consequently, the three cusp portions of the wireforms 144, 146 are relatively free to expand and contract with the surrounding annulus and ascending aorta, thus improving hemodynamics. Furthermore, the highly flexible nature of the dual-wireform valve 140 facilitates a subsequent valve-in-valve procedure. Over time, prosthetic heart valves may experience reduced performance from calcification, for example, requiring replacement. One technique available is to implant an expandable valve directly inside the existing prosthetic valve. However, prior surgical valves typically have rigid annular internal frames or stents, so that the second valve cannot be expanded to the same orifice diameter. With the highly flexible dual-wireform valve 140, however, a subsequently implanted valve can be balloon expanded and force the first valve open. The cusp regions separate from the outward force, and the new valve will then expand to a suitable diameter without sacrificing any flow volume from the valve-in-valve procedure.



FIGS. 19A and 19B show upper and lower wireforms 160, 162 for use in an alternative dual-wireform prosthetic heart valve. The upper wireform 160 has substantially the same configuration as those described above, with alternating arcuate cusps 164 and inverted U-shaped commissures 166. The lower wireform 162 on the other hand is truncated with three arcuate valleys 170 that match the shape of the upper wireform cusps 164 and three upstanding peaks 172 that extend only partway up the upper wireform commissures 166. In one embodiment, the height of the lower wireform 162 at the peaks 172 is about one half the height of the upper wireform 160 at the commissures 166. The assembled wireform structure seen in FIG. 19B shows the upper wireform commissures 166 generally unsupported by the lower wireform 162. Flexible leaflets 180 are supported by the combination of the upper and lower wireforms 160, 162, and are shown schematically without connecting structure merely to indicate their placement. As will be explained, both the upper and lower wireforms 160, 162 are typically covered with fabric to facilitate their attachment to each other and to the leaflets 180 using sutures or the like.


In a similar manner as the version of FIG. 15, a sewing ring (not shown) may attach around the cusp portions of the wireforms 160, 162, with gaps at the commissures regions filled-in with fabric or other such material to prevent leakage. For instance, a sewing ring such as the cloth tab 150 seen in FIGS. 18A and 18B may be used. Peripheral edges of the flexible leaflets 180 are desirably sandwiched between the two wireforms 160, 162 at least in the cusp regions, much like was described above with respect to FIGS. 17A-17C.



FIGS. 20A and 20B show a commissure post region of an assembled heart valve illustrating a manner of attaching the flexible leaflets 180 to the upper wireform commissures 166. In particular, a cloth (polyester fabric) covering 182 that extends along the length of the upper wireform 160 includes tab extensions 184 at the upper regions of the commissures 166 to which leaflet tabs 186 are sewn. The leaflet tabs 186 project radially outward between the spaced wires of the commissures 166 and between the cloth tab extensions 184. FIG. 20A shows a partial assembly to make clear the connection, and the combined tab of the cloth tab extensions 184 and leaflet tabs 186 are preferably rolled or folded and sewn with sutures 188 into a bundle 190 outside of the commissures 166 as seen in FIG. 20B. This bundle 190 is larger than the gap between the spaced wires of the commissures 166, and thus the leaflet tabs 186 are secured to the commissures 166 and have little stress imparted to the connecting sutures 188 because of the bundled configuration. Optionally, a small insert (not shown) of stiffer cloth or polymer may be rolled up within the bundle 190 for additional bulk to maintain the bundle on the outside of the commissures 166.


While the invention has been described in its preferred embodiments, it is to be understood that the words which have been used are words of description and not of limitation. Therefore, changes may be made within the appended claims without departing from the true scope of the invention.

Claims
  • 1. A prosthetic heart valve, comprising: a first undulating wireform comprising an elongated rod-like structure having a peripheral shape continuously alternating around a central axis, three curvilinear cusps on an inflow end and three curvilinear commissures on an outflow end;a second undulating wireform comprising an elongated rod-like structure having a peripheral shape continuously alternating around the axis, three curvilinear cusps on an inflow end and three curvilinear commissures on an outflow end, wherein the first and second wireforms are separate elements,wherein the cusps and commissures of the two wireforms are circumferentially aligned around the axis with the aligned cusps positioned adjacent to one another while the commissures of the first wireform are shorter in height than the commissures of the second wireform, and wherein the heart valve has no rigid annular components; and wherein the heart valve has no rigid annular components; anda plurality of flexible leaflets having outer edges secured at the cusps of the first and second undulating wireforms, wherein the cusps of the first wireform are located axially below the cusps of the second wireform and the outer edges of the flexible leaflets are secured therebetween.
  • 2. The heart valve of claim 1, wherein both the first wireform and second wireform are covered with fabric and wherein the flexible leaflets have commissure tabs that extend outward through the inverted U-shaped commissures of the second fabric-covered wireform and are secured to cloth tabs extending from the fabric covering on the second wireform.
  • 3. The heart valve of claim 1, wherein a cross-sectional shape through the first wireform is dissimilar from a cross-sectional shape through the second wireform.
  • 4. The heart valve of claim 1, wherein both the first wireform and second wireform are covered with fabric and the outer edges of the flexible leaflets are secured between the respective cusps with sutures.
  • 5. The heart valve of claim 1, wherein the flexible leaflets each have commissure tabs that extend outward through the commissures of the second wireform and are secured to cloth tabs extending from a cloth covering on the second wireform.
  • 6. The heart valve of claim 5, wherein an assembly of the leaflet commissure tabs and cloth tabs on adjacent portions of each commissure of the second cloth-covered wireform is rolled or folded and sewn together outside of that commissure.
  • 7. The heart valve of claim 1, wherein both the first wireform and second wireform are covered with fabric and a cloth tab on one of the wireforms encompasses a small piece of silicone ribbon at least at the cusps thereof to provide a sewing ring.
  • 8. The heart valve of claim 1, wherein the cusps of both wireforms curve in an inflow direction and the commissures of the second wireform define upstanding commissure posts with inverted U-shapes projecting in an outflow direction, and the commissures of the first wireform are about one half the height of the commissures of the second wireform.
  • 9. The heart valve of claim 1, wherein both the first wireform and second wireform are separately covered with fabric and then joined with sutures with outer edges of the flexible leaflets sandwiched therebetween.
  • 10. The heart valve of claim 1, wherein both the first wireform and second wireform are formed of the same material.
  • 11. A prosthetic heart valve, comprising: a first undulating wireform comprising a preformed wire having a peripheral shape continuously alternating around a central axis, three curvilinear cusps on an inflow end and three curvilinear commissures on an outflow end;a second undulating wireform comprising a preformed wire having a peripheral shape continuously alternating around the axis, three curvilinear cusps on an inflow end and three curvilinear commissures on an outflow end, wherein the first and second wireforms are separate elements;wherein the cusps and commissures of the two wireforms are circumferentially aligned around the axis with the aligned cusps positioned adjacent to one another while the commissures of the first wireform are shorter in height than the commissures of the second wireform, and wherein the heart valve has no rigid annular components; and wherein the heart valve has no rigid annular components; anda plurality of flexible leaflets having outer edges secured at the cusps of the first and second undulating wireforms, wherein the second wireform is located axially above the first wireform with no axially overlapping portions.
  • 12. The heart valve of claim 11, wherein both the first wireform and second wireform are covered with fabric and the outer edges of the flexible leaflets are secured between the respective cusps with sutures.
  • 13. The heart valve of claim 11, wherein the cusps of both wireforms curve in an inflow direction and the commissures of the second wireform define upstanding commissure posts with inverted U-shapes projecting in an outflow direction, and the commissures of the first wireform are about one half the height of the commissures of the second wireform.
  • 14. The heart valve of claim 11, wherein both the first wireform and second wireform are formed of the same material.
  • 15. The heart valve of claim 11, wherein both the first wireform and second wireform are separately covered with fabric and then joined with sutures with outer edges of the flexible leaflets sandwiched therebetween.
  • 16. The heart valve of claim 11, wherein the flexible leaflets each have commissure tabs that extend outward through the commissures of the second wireform and are secured to cloth tabs extending from a cloth covering on the second wireform.
  • 17. The heart valve of claim 16, wherein an assembly of the leaflet commissure tabs and cloth tabs on adjacent portions of each commissure of the second cloth-covered wireform is rolled or folded and sewn together outside of that commissure.
  • 18. The heart valve of claim 11, wherein both the first wireform and second wireform are covered with fabric and a cloth tab on one of the wireforms encompasses a small piece of silicone ribbon at least at the cusps thereof to provide a sewing ring.
  • 19. The heart valve of claim 11, wherein the first and second undulating wireforms are cloth-covered, and the outer edges of the flexible leaflets are sandwiched between the cusps of the first and second wireforms.
  • 20. The heart valve of claim 11, wherein the cusps of both wireforms curve in an inflow direction and the commissures of the second wireform define upstanding commissure posts with inverted U-shapes projecting in an outflow direction, and the first wireform has truncated commissures of about one half the height of the commissures of the second wireform.
RELATED APPLICATIONS

The present application claims priority under 35 U.S.C. § 119 to U.S. Provisional Application Ser. No. 61/880,688, filed Sep. 20, 2013.

US Referenced Citations (353)
Number Name Date Kind
3143742 Cromie Aug 1964 A
3320972 High et al. May 1967 A
3371352 Siposs et al. Mar 1968 A
3546710 Shumakov et al. Dec 1970 A
3570014 Hancock Mar 1971 A
3574865 Hamaker Apr 1971 A
3755823 Hancock Sep 1973 A
3839741 Haller Oct 1974 A
3997923 Possis Dec 1976 A
4035849 Angell et al. Jul 1977 A
4078468 Civitello Mar 1978 A
4079468 Liotta et al. Mar 1978 A
4084268 Ionescu et al. Apr 1978 A
4106129 Carpentier et al. Aug 1978 A
4172295 Batten Oct 1979 A
4217665 Bex et al. Aug 1980 A
4218782 Rygg Aug 1980 A
4259753 Liotta et al. Apr 1981 A
RE30912 Hancock Apr 1982 E
4340091 Skelton et al. Jul 1982 A
4343048 Ross Aug 1982 A
4345340 Rosen Aug 1982 A
4364126 Rosen et al. Dec 1982 A
4388735 Ionescu et al. Jun 1983 A
4441216 Ionescu et al. Apr 1984 A
4451936 Carpentier et al. Jun 1984 A
4470157 Love Sep 1984 A
4490859 Black et al. Jan 1985 A
4501030 Lane Feb 1985 A
4506394 Bedard Mar 1985 A
4535483 Klawitter et al. Aug 1985 A
4566465 Arhan et al. Jan 1986 A
4605407 Black et al. Aug 1986 A
4626255 Reichart et al. Dec 1986 A
4629459 Ionescu et al. Dec 1986 A
4680031 Alonso Jul 1987 A
4687483 Fisher et al. Aug 1987 A
4705516 Barone et al. Nov 1987 A
4725274 Lane Feb 1988 A
4731074 Rousseau et al. Mar 1988 A
4778461 Pietsch et al. Oct 1988 A
4790843 Carpentier et al. Dec 1988 A
4851000 Gupta Jul 1989 A
4888009 Lederman et al. Dec 1989 A
4914097 Oda et al. Apr 1990 A
4960424 Grooters Oct 1990 A
4993428 Arms Feb 1991 A
5010892 Colvin et al. Apr 1991 A
5032128 Alonso Jul 1991 A
5037434 Lane Aug 1991 A
5147391 Lane Sep 1992 A
5163955 Love et al. Nov 1992 A
5258023 Reger Nov 1993 A
5316016 Adams et al. May 1994 A
5326370 Love et al. Jul 1994 A
5326371 Love et al. Jul 1994 A
5332402 Teitelbaum Jul 1994 A
5360014 Sauter et al. Nov 1994 A
5360444 Kusuhara Nov 1994 A
5376112 Duran Dec 1994 A
5396887 Imran Mar 1995 A
5397351 Pavcnik et al. Mar 1995 A
5415667 Frater May 1995 A
5423887 Love et al. Jun 1995 A
5425741 Lemp et al. Jun 1995 A
5431676 Dubrul et al. Jul 1995 A
5449384 Johnson Sep 1995 A
5449385 Religa et al. Sep 1995 A
5469868 Reger Nov 1995 A
5488789 Religa et al. Feb 1996 A
5489296 Love et al. Feb 1996 A
5489297 Duran Feb 1996 A
5489298 Love et al. Feb 1996 A
5500016 Fisher Mar 1996 A
5533515 Coller et al. Jul 1996 A
5549665 Vesely Aug 1996 A
5562729 Purdy et al. Oct 1996 A
5571215 Sterman et al. Nov 1996 A
5573007 Bobo, Sr. Nov 1996 A
5578076 Krueger et al. Nov 1996 A
5584803 Stevens et al. Dec 1996 A
5618307 Donlon et al. Apr 1997 A
5626607 Malecki et al. May 1997 A
5628789 Vanney et al. May 1997 A
5693090 Unsworth et al. Dec 1997 A
5695503 Krueger et al. Dec 1997 A
5697382 Love Dec 1997 A
5713952 Vanney et al. Feb 1998 A
5716370 Williamson, IV et al. Feb 1998 A
5728064 Burns et al. Mar 1998 A
5728151 Garrison et al. Mar 1998 A
5735894 Krueger et al. Apr 1998 A
5752522 Murphy May 1998 A
5755782 Love et al. May 1998 A
5766240 Johnson Jun 1998 A
5800527 Jansen et al. Sep 1998 A
5814097 Sterman et al. Sep 1998 A
5814098 Hinnenkamp et al. Sep 1998 A
5824064 Taheri Oct 1998 A
5824068 Bugge Oct 1998 A
5840081 Andersen et al. Nov 1998 A
5848969 Panescu et al. Dec 1998 A
5855563 Kaplan et al. Jan 1999 A
5855601 Bessler et al. Jan 1999 A
5855801 Lin et al. Jan 1999 A
5891160 Williamson, IV et al. Apr 1999 A
5895420 Mirsch, II et al. Apr 1999 A
5902308 Murphy May 1999 A
5908450 Gross et al. Jun 1999 A
5919147 Jain Jul 1999 A
5921934 Teo Jul 1999 A
5921935 Hickey Jul 1999 A
5924984 Rao Jul 1999 A
5928281 Huynh et al. Jul 1999 A
5957949 Leonhardt et al. Sep 1999 A
5972004 Williamson, IV et al. Oct 1999 A
5984959 Robertson et al. Nov 1999 A
5984973 Girard et al. Nov 1999 A
6010531 Donlon et al. Jan 2000 A
6042554 Rosenman et al. Mar 2000 A
6042607 Williamson, IV et al. Mar 2000 A
6066160 Colvin et al. May 2000 A
6074418 Buchanan et al. Jun 2000 A
6081737 Shah Jun 2000 A
6083179 Oredsson Jul 2000 A
6099475 Seward et al. Aug 2000 A
6102944 Huynh Aug 2000 A
6106550 Magovern et al. Aug 2000 A
6110200 Hinnenkamp Aug 2000 A
6117091 Young et al. Sep 2000 A
6126007 Kari et al. Oct 2000 A
6162233 Williamson, IV et al. Dec 2000 A
6168614 Andersen et al. Jan 2001 B1
6176877 Buchanan et al. Jan 2001 B1
6197054 Hamblin, Jr. et al. Mar 2001 B1
6217611 Klostermeyer Apr 2001 B1
6231561 Frazier et al. May 2001 B1
6231602 Carpentier May 2001 B1
6241765 Griffin et al. Jun 2001 B1
6245102 Jayaraman Jun 2001 B1
6264611 Ishikawa et al. Jul 2001 B1
6283127 Sterman et al. Sep 2001 B1
6287339 Vazquez et al. Sep 2001 B1
6290674 Roue et al. Sep 2001 B1
6312447 Grimes Nov 2001 B1
6312465 Griffin et al. Nov 2001 B1
6328727 Frazier et al. Dec 2001 B1
6350282 Eberhardt Feb 2002 B1
6371983 Lane Apr 2002 B1
6375620 Oser et al. Apr 2002 B1
6402780 Williamson, IV et al. Jun 2002 B2
6425916 Garrison et al. Jul 2002 B1
6440164 Di Matte et al. Aug 2002 B1
6454799 Schreck Sep 2002 B1
6458153 Bailey et al. Oct 2002 B1
6461382 Cao Oct 2002 B1
6468305 Otte Oct 2002 B1
6478819 Moe Nov 2002 B2
6491624 Lotfi Dec 2002 B1
6558418 Carpentier et al. May 2003 B2
6562069 Cai May 2003 B2
6582462 Andersen et al. Jun 2003 B1
6585766 Huynh et al. Jul 2003 B1
6652578 Bailey et al. Nov 2003 B2
6682559 Myers et al. Jan 2004 B2
6685739 DiMatteo et al. Feb 2004 B2
6730118 Spenser et al. May 2004 B2
6733525 Yang et al. May 2004 B2
6764508 Roehe et al. Jul 2004 B1
6767362 Schreck Jul 2004 B2
6773457 Ivancev et al. Aug 2004 B2
6786925 Schoon et al. Sep 2004 B1
6790229 Berreklouw Sep 2004 B1
6790230 Beyersdorf et al. Sep 2004 B2
6805711 Quijano et al. Oct 2004 B2
6893459 Macoviak May 2005 B1
6893460 Spenser et al. May 2005 B2
6908481 Cribier Jun 2005 B2
6939365 Fogarty et al. Sep 2005 B1
7011681 Vesely Mar 2006 B2
7025780 Gabbay Apr 2006 B2
7070616 Majercak et al. Jul 2006 B2
7097659 Woolfson et al. Aug 2006 B2
7101396 Artof et al. Sep 2006 B2
7147663 Berg et al. Dec 2006 B1
7153324 Case et al. Dec 2006 B2
7195641 Palmaz et al. Mar 2007 B2
7201771 Lane Apr 2007 B2
7201772 Schwammenthal et al. Apr 2007 B2
7238200 Lee et al. Jul 2007 B2
7252682 Seguin Aug 2007 B2
7261732 Justino Aug 2007 B2
RE40377 Williamson, IV et al. Jun 2008 E
7399315 Iobbi Jul 2008 B2
7422603 Lane Sep 2008 B2
7470285 Nugent Dec 2008 B2
7513909 Lane et al. Apr 2009 B2
7556647 Drews et al. Jul 2009 B2
7569072 Berg et al. Aug 2009 B2
7871436 Ryan Jan 2011 B2
7998151 St. Goar et al. Aug 2011 B2
20010039435 Roue et al. Nov 2001 A1
20010039436 Frazier et al. Nov 2001 A1
20010041914 Frazier et al. Nov 2001 A1
20010041915 Roue et al. Nov 2001 A1
20010049492 Frazier et al. Dec 2001 A1
20020020074 Love et al. Feb 2002 A1
20020026238 Lane et al. Feb 2002 A1
20020032481 Gabbay Mar 2002 A1
20020058995 Stevens May 2002 A1
20020123802 Snyders Sep 2002 A1
20020138138 Yang Sep 2002 A1
20020151970 Garrison et al. Oct 2002 A1
20020173842 Buchanan Nov 2002 A1
20020188348 DiMatteo et al. Dec 2002 A1
20020198594 Schreck Dec 2002 A1
20030014104 Cribier Jan 2003 A1
20030023300 Bailey et al. Jan 2003 A1
20030023303 Palmaz et al. Jan 2003 A1
20030036795 Andersen et al. Feb 2003 A1
20030040792 Gabbay Feb 2003 A1
20030055495 Pease et al. Mar 2003 A1
20030105519 Fasol et al. Jun 2003 A1
20030109924 Cribier Jun 2003 A1
20030114913 Spenser et al. Jun 2003 A1
20030130729 Paniagua et al. Jul 2003 A1
20030149478 Figulla et al. Aug 2003 A1
20030167089 Lane Sep 2003 A1
20030195620 Huynh et al. Oct 2003 A1
20030236568 Hojeibane et al. Dec 2003 A1
20040019374 Hojeibane et al. Jan 2004 A1
20040034411 Quijano et al. Feb 2004 A1
20040044406 Woolfson et al. Mar 2004 A1
20040106976 Bailey et al. Jun 2004 A1
20040122514 Fogarty et al. Jun 2004 A1
20040122516 Fogarty et al. Jun 2004 A1
20040167573 Williamson et al. Aug 2004 A1
20040186563 Lobbi Sep 2004 A1
20040186565 Schreck Sep 2004 A1
20040193261 Berreklouw Sep 2004 A1
20040206363 McCarthy et al. Oct 2004 A1
20040210304 Seguin et al. Oct 2004 A1
20040210307 Khairkhahan Oct 2004 A1
20040225355 Stevens Nov 2004 A1
20040236411 Sarac et al. Nov 2004 A1
20040260389 Case et al. Dec 2004 A1
20040260390 Sarac et al. Dec 2004 A1
20050010285 Lambrecht et al. Jan 2005 A1
20050027348 Case et al. Feb 2005 A1
20050033398 Seguin Feb 2005 A1
20050043760 Fogarty et al. Feb 2005 A1
20050043790 Seguin Feb 2005 A1
20050060029 Le et al. Mar 2005 A1
20050065594 DiMatteo et al. Mar 2005 A1
20050065614 Stinson Mar 2005 A1
20050075584 Cali Apr 2005 A1
20050075713 Biancucci et al. Apr 2005 A1
20050075717 Nguyen et al. Apr 2005 A1
20050075718 Nguyen et al. Apr 2005 A1
20050075719 Bergheim Apr 2005 A1
20050075720 Nguyen et al. Apr 2005 A1
20050075724 Svanidze et al. Apr 2005 A1
20050080454 Drews et al. Apr 2005 A1
20050096738 Cali et al. May 2005 A1
20050096739 Cao May 2005 A1
20050137682 Justino Jun 2005 A1
20050137686 Salahieh et al. Jun 2005 A1
20050137687 Salahieh et al. Jun 2005 A1
20050137688 Salahieh et al. Jun 2005 A1
20050137690 Salahieh et al. Jun 2005 A1
20050137692 Haug et al. Jun 2005 A1
20050137695 Salahieh et al. Jun 2005 A1
20050159811 Lane Jul 2005 A1
20050165479 Drews et al. Jul 2005 A1
20050182486 Gabbay Aug 2005 A1
20050192665 Spenser et al. Sep 2005 A1
20050203616 Cribier Sep 2005 A1
20050203617 Forster et al. Sep 2005 A1
20050203618 Sharkawy et al. Sep 2005 A1
20050216079 MaCoviak Sep 2005 A1
20050222674 Paine Oct 2005 A1
20050228494 Marquez Oct 2005 A1
20050234546 Nugent et al. Oct 2005 A1
20050240263 Fogarty et al. Oct 2005 A1
20050251252 Stobie Nov 2005 A1
20050261765 Liddicoat Nov 2005 A1
20050283231 Haug et al. Dec 2005 A1
20060025857 Bergheim et al. Feb 2006 A1
20060052867 Revuelta et al. Mar 2006 A1
20060058871 Zakay et al. Mar 2006 A1
20060058872 Salahieh et al. Mar 2006 A1
20060074484 Huber Apr 2006 A1
20060085060 Campbell Apr 2006 A1
20060095125 Chinn et al. May 2006 A1
20060122634 Ino et al. Jun 2006 A1
20060149360 Schwammenthal et al. Jul 2006 A1
20060154230 Cunanan et al. Jul 2006 A1
20060167543 Bailey et al. Jul 2006 A1
20060195184 Lane et al. Aug 2006 A1
20060195185 Lane et al. Aug 2006 A1
20060195186 Drews et al. Aug 2006 A1
20060207031 Cunanan et al. Sep 2006 A1
20060241745 Solem Oct 2006 A1
20060259136 Nguyen et al. Nov 2006 A1
20060271172 Tehrani Nov 2006 A1
20060271175 Woolfson et al. Nov 2006 A1
20060287717 Rowe et al. Dec 2006 A1
20060287719 Rowe et al. Dec 2006 A1
20060293745 Carpentier Dec 2006 A1
20070005129 Damm et al. Jan 2007 A1
20070010876 Salahieh et al. Jan 2007 A1
20070016285 Lane et al. Jan 2007 A1
20070016286 Herrmann et al. Jan 2007 A1
20070016288 Gurskis et al. Jan 2007 A1
20070043435 Seguin et al. Feb 2007 A1
20070078509 Lotfy Apr 2007 A1
20070078510 Ryan Apr 2007 A1
20070100440 Figulla et al. May 2007 A1
20070129794 Realyvasquez Jun 2007 A1
20070142906 Figulla et al. Jun 2007 A1
20070142907 Moaddeb et al. Jun 2007 A1
20070150053 Gurskis et al. Jun 2007 A1
20070156233 Kapadia et al. Jul 2007 A1
20070162103 Case et al. Jul 2007 A1
20070162107 Haug et al. Jul 2007 A1
20070162111 Fukamachi et al. Jul 2007 A1
20070179604 Lane Aug 2007 A1
20070185565 Schwammenthal et al. Aug 2007 A1
20070198097 Zegdi Aug 2007 A1
20070203575 Forster et al. Aug 2007 A1
20070203576 Lee et al. Aug 2007 A1
20070213813 Von Segesser et al. Sep 2007 A1
20070225801 Drews et al. Sep 2007 A1
20070233237 Krivoruchko Oct 2007 A1
20070239266 Birdsall Oct 2007 A1
20070239269 Dolan et al. Oct 2007 A1
20070239273 Allen Oct 2007 A1
20070255398 Yang et al. Nov 2007 A1
20070260305 Drews et al. Nov 2007 A1
20070265701 Gurskis et al. Nov 2007 A1
20070270944 Bergheim et al. Nov 2007 A1
20070282436 Pinchuk Dec 2007 A1
20070288089 Gurskis et al. Dec 2007 A1
20080033543 Gurskis et al. Feb 2008 A1
20080119875 Ino et al. May 2008 A1
20080154356 Obermiller et al. Jun 2008 A1
20080294248 Yang et al. Nov 2008 A1
20080319543 Lane Dec 2008 A1
20090036903 Ino et al. Feb 2009 A1
20090157175 Benichou Jun 2009 A1
20090192599 Lane et al. Jul 2009 A1
20100049313 Alon et al. Feb 2010 A1
20120296418 Bonyuet et al. Nov 2012 A1
Foreign Referenced Citations (9)
Number Date Country
0116236 Aug 1984 EP
0125393 Nov 1984 EP
0143246 Jun 1985 EP
2149062 Jun 1985 GB
1116573 Jul 1985 SU
1697790 Dec 1991 SU
9213502 Aug 1992 WO
9742871 Nov 1997 WO
2012047761 Apr 2012 WO
Non-Patent Literature Citations (1)
Entry
International Search Report from corresponding PCT case No. PCT/US2014/056070 dated Dec. 24, 2014.
Related Publications (1)
Number Date Country
20150088250 A1 Mar 2015 US
Provisional Applications (1)
Number Date Country
61880688 Sep 2013 US